Lundoch

Based in Sweden, Lundoch is a startup. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Lundoch develops an AI-driven diagnostic tool that uses blood levels of follistatin as a biomarker to predict and assess the risk of type 2 diabetes up to four years before diagnosis, enabling early detection and precision prevention of diabetes-related complications.